首页|维持性血液透析联合西那卡塞对终末期肾病患者的治疗效果

维持性血液透析联合西那卡塞对终末期肾病患者的治疗效果

扫码查看
目的 研究分析终末期肾病患者应用维持性血液透析联合西那卡塞治疗的效果.方法 76 例终末期肾病患者,依据双色球法分成两组,即对照组和研究组,各 38 例.对照组采用维持性血液透析,研究组则在对照组的基础上加用西那卡塞治疗.对比两组血清磷、钙浓度,甲状旁腺机能,肾功能水平,炎症指标,血常规、血生化.结果 治疗后,两组患者的血清磷浓度明显较治疗前降低、血清钙浓度明显较治疗前升高,具有统计意义(P<0.05);两组治疗后的血清钙浓度相差不大(P>0.05),但研究组患者治疗后的血清磷浓度(1.70±0.13)mmol/L低于对照组的(1.96±0.20)mmol/L,具有统计意义(P<0.05).治疗后,研究组患者的全段甲状旁腺激素为(138.95±22.66)ng/L、碱性磷酸酶为(81.30±6.38)U/L,均低于对照组患者的(329.63±47.35)ng/L、(101.25±14.95)U/L,具有统计意义(t=22.392、7.566,P=0.000、0.000<0.05).治疗后,研究组患者的血肌酐为(523.63±9.14)μmol/L、血尿素氮为(18.82±1.81)mmol/L,均低于对照组患者的(639.63±11.24)μmol/L、(19.95±2.58)mmol/L,具有统计意义(t=49.359、2.210,P=0.000、0.030<0.05).治疗后,研究组患者的降钙素原为(0.59±0.03)ng/ml、超敏C反应蛋白为(5.35±1.29)mg/L,均低于对照组患者的(0.65±0.03)ng/ml、(7.55±1.50)mg/L,具有统计意义(t=8.718、6.855,P=0.000、0.000<0.05).治疗后,研究组患者的白蛋白为(34.52±0.41)g/L、球蛋白为(23.14±0.31)g/L、白细胞计数为(5.11±0.21)×109/L,高于对照组的(32.11±0.31)g/L、(21.33±0.30)g/L、(4.62±0.22)×109/L,具有统计意义(t=28.903、25.864、9.932,P=0.000、0.000、0.000<0.05).结论 终末期肾病患者联合应用维持性血液透析和西那卡塞的效果显著,能够保持血磷水平稳定,促进提升肾功能,值得推广利用.
Effect of maintenance hemodialysis combined with cinacalcet on patients with end-stage renal disease
Objective To study and analyze the effect of maintenance hemodialysis combined with cinacalcet on patients with end-stage renal disease.Methods 76 patients with end-stage renal disease were divided into two groups,i.e.,the control group and the study group,each with 38 cases.The control group was treated with maintenance hemodialysis,and the study group was treated with cinacalcet on the basis of the control group.The serum phosphorus and calcium concentration,parathyroid function,renal function,inflammatory markers,blood routine and blood biochemistry were compared between the two groups.Results After treatment,the serum phosphorus concentration was significantly lower and the serum calcium concentration was significantly higher than those before treatment in both groups,and there was statistical significance(P<0.05).There was no significant difference in serum calcium concentration between the two groups after treatment(P>0.05).The serum phosphorus concentration in the study group was(1.70±0.13)mmol/L after treatment,which was lower than(1.96±0.20)mmol/L in the control group,and there was statistical significance(P<0.05).After treatment,the intact parathyroid hormone and alkaline phosphatase in the study group were(138.95±22.66)ng/L and(81.30±6.38)U/L,which were lower than(329.63±47.35)ng/L and(101.25±14.95)U/L in the control group,and there was statistical significance(t=22.392,7.566;P=0.000,0.000<0.05).After treatment,the serum creatinine of the study group was(523.63±9.14)μmol/L and blood urea nitrogen was(18.82±1.81)mmol/L,which were lower than(639.63±11.24)μmol/L and(19.95±2.58)mmol/L of the control group,and there was statistical significance(t=49.359,2.210;P=0.000,0.030<0.05).After treatment,the levels of procalcitonin and hypersensitive C-reactive protein in the study group were(0.59±0.03)ng/ml and(5.35±1.29)mg/L,both were lower than(0.65±0.03)ng/ml and(7.55±1.50)mg/L in the control group,and there was statistical significance(t=8.718,6.855;P=0.000,0.000<0.05).After treatment,the albumin of the study group was(34.52±0.41)g/L,the globulin was(23.14±0.31)g/L,and the white blood cell count was(5.11±0.21)×109/L,which were higher than(32.11±0.31)g/L,(21.33±0.30)g/L,and(4.62±0.22)×109/L of the control group,and there was statistical significance(t=28.903,25.864,9.932;P=0.000,0.000,0.000<0.05).Conclusion The combined application of maintenance hemodialysis and cinacalcet in patients with end-stage renal disease has a remarkable effect,which can stable the blood phosphorus level and promote the improvement of renal function,and is worthy of promotion and utilization.

Maintenance hemodialysisCinacalcetEnd-stage renal diseaseRenal function

孙崇勇、谢荣兰

展开 >

276004 山东省临沂市交通医院

维持性血液透析 西那卡塞 终末期肾病 肾功能

2024

中国实用医药
中国康复医学会

中国实用医药

影响因子:0.797
ISSN:1673-7555
年,卷(期):2024.19(14)